FINNENCE ▪ THE WIRE FILE
THE WIRE · № 77010
News■ Mixed
McKesson: Re-Rated Again Amidst Increased M&A Efforts (NYSE:MCK)
KINDNews
DIRECTION■ Mixed
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN
LAST UPDATE
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Re-rating reflects M&A strategy, but the piece is analyst opinion without new financial disclosures.
McKesson re-rating hinges on capital deployment
CATALYST TO WATCH
Announced deals or guidance update
MAIN RISK
Overpaying for acquisitions compresses returns
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Rona Therapeutics enters into global license agreement with Roche for ALK7-targeting RNAi therapy for obesity and metabolic diseases2026-10-13 07:00 UTC
Rona Therapeutics enters into global license agreement with Roche for ALK7-targeting RNAi therapy for obesity and metabolic diseases2026-10-13 07:00 UTC
←CORRELATIONshares Healthcare
Gottlieb on how AI is assisting in the development of cancer vaccines2026-10-12 19:00 UTC
Gottlieb on how AI is assisting in the development of cancer vaccines2026-10-12 19:00 UTC
←CORRELATIONshares Healthcare
Why This IPO Stock, An AnaptysBio Spinoff, Just Surged2026-10-12 20:10 UTC
Why This IPO Stock, An AnaptysBio Spinoff, Just Surged2026-10-12 20:10 UTC
←CORRELATIONshares Healthcare
Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care2026-10-12 20:25 UTC
Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care2026-10-12 20:25 UTC
←CORRELATIONshares Healthcare
ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus2026-10-12 20:30 UTC
ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus2026-10-12 20:30 UTC
←CORRELATIONshares Healthcare
Corcept Seeks to Block Ex-Judge’s Testimony in Teva Antitrust Fight2026-10-12 20:58 UTC
Corcept Seeks to Block Ex-Judge’s Testimony in Teva Antitrust Fight2026-10-12 20:58 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.